Cefprozil, a second-generation cephalosporin antibiotic, can be used to treat bronchitis or other bacterial infections. Cefpropene has obvious effect on Staphylococcus aureus (including β - lactamase producing strain), Streptococcus pneumoniae and Streptococcus pyogenesis in Gram-positive aerobic bacteria, and has certain antibacterial activity to Enterococcus Fortis, Listeria monocytogenes, Staphylococcus epidermidis, Staphylococcus saprophytis and Staphylococcus warnei.
1. Upper respiratory tract infection, such as suppurative streptococcal pharyngitis, tonsillitis.
2. Lower respiratory tract infections, such as acute bronchitis and acute exacerbations of chronic bronchitis caused by Streptococcus pneumoniae, Haemophilus influenzae (including beta lactamase producing strains) and Moraxella catarrhalis (including beta lactamase producing strains).
3. Skin and skin soft tissue infections, such as non complex skin and skin soft tissue infections caused by Staphylococcus aureus (including penicillinase producing strains) and Streptococcus pyogenes.